N
Needham Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
526
Vir Biotechnology
VIR
$714M
|
AC
Alan Carr
| $5.14 | $62 |
1,106%
upside
| Buy | 5 years ago |
|
527
OneSpan
OSPN
$583M
| $15.20 | $29 |
91%
upside
| Buy | 5 years ago |
|
|
528
Electronic Arts
EA
$42B
|
LM
Laura Martin
| $168.03 | $165 |
2%
downside
| Buy | 5 years ago |
|
529
WIX.com
WIX
$8.19B
|
BE
Brad Erickson
| $147.15 | $340 |
131%
upside
| Buy | 5 years ago |
|
530
Danaher
DHR
$143B
|
SU
Stephen Unger
| $199.03 | $209 |
5%
upside
| Buy | 5 years ago |
|
531
Dynatrace
DT
$15B
| $49.77 | $50 |
0%
upside
| Buy | 5 years ago |
|
|
532
Shutterstock
SSTK
$730M
|
BE
Brad Erickson
| $20.59 | $50 |
143%
upside
| Buy | 5 years ago |
|
533
AudioCodes
AUDC
$275M
|
RV
Richard Valera
| $9.70 | $42 |
333%
upside
| Buy | 5 years ago |
|
534
Vaxcyte
PCVX
$4.17B
|
AC
Alan Carr
| $32.15 | $40 |
24%
upside
| Buy | 5 years ago |
|
535
Oxford Industries
OXM
$636M
|
RP
Rick Patel
| $42.60 | $62 |
46%
upside
| Buy | 5 years ago |
|
536
Alnylam Pharmaceuticals
ALNY
$59.4B
|
AC
Alan Carr
| $453.54 | $160 |
65%
downside
| Buy | 5 years ago |
|
537
Akebia Therapeutics
AKBA
$801M
|
CM
Chad Messer
| $3.02 | $18 |
496%
upside
| Buy | 5 years ago |
|
538
G-III Apparel Group
GIII
$1.2B
|
RP
Rick Patel
| $27.63 | $21 |
24%
downside
| Buy | 5 years ago |
|
539
Cidara Therapeutics
CDTX
$1.65B
|
AC
Alan Carr
| $64.93 | $120 |
85%
upside
| Buy | 5 years ago |
|
540
Acushnet Holdings
GOLF
$4.47B
| $76.19 | $28 |
63%
downside
| Equal-Weight | 5 years ago |
|
|
|
ACB
541
Aurora Cannabis
ACB
$272M
|
MM
Matt McGinley
| $4.83 | $18 |
273%
upside
| Hold | 5 years ago |
|
542
Agilent Technologies
A
$36.4B
|
SU
Stephen Unger
| $128.48 | $85 |
34%
downside
| Hold | 5 years ago |
|
|
EH
543
EHang Holdings
EH
$1.16B
|
VY
Vincent Yu
| $16.10 | $14 |
13%
downside
| Buy | 5 years ago |
|
544
Teleflex
TFX
$5.7B
|
MM
Michael Matson
| $129.09 | $423 |
228%
upside
| Buy | 5 years ago |
|